Health

Results: 1681-1692 of 9521

ViiV Healthcare’s long-acting Cabenuva (cabotegravir + rilpivirine) for HIV demonstrates superior efficacy compared to daily oral therapy for people with adherence challenges; results published in NEJM

Hansa Biopharma's Biologics License Application (BLA) for imlifidase accepted by the FDA

Thea announces roadmap aligned with global climate neutrality objectives

PR Newswire associated0

Clario Leads the Way in Responsible Artificial Intelligence with ISO 42001 certification, audited by Schellman

Business Wire logo

FDA Approval Granted for Commercial Manufacturing at Rezon Bio's Warsaw-Duchnice Facility

PR Newswire associated0

FDA Grants Breakthrough Device Designation to Two Rapid Tests Targeting Critical Drug-Resistant Pathogens

Year-end report 2025: New CEO takes the helm - initiates the next phase of Enzymatica's international expansion

PR Newswire associated0

Skingevity Launches as New UK Medical Aesthetics Clinic Group with Acquisition of Three Leading Practices

BioArctic Interim Report for the period October - December 2025

Sobi Capital Markets Day 2026: Bringing brilliant ideas to life and building the next chapter with ambition to deliver SEK 55bn by 2030

PR Newswire associated0

Mammotome Launches First In-Room MR Vacuum-Assisted Breast Biopsy System

Photocure ASA: Results for the fourth quarter of 2025